Natco Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA7103630
EBIT5932200
Earning Per Share24939
Expenses1,4461,6811,772
Net Profit442170715
Net Profit Margin22926
Operating Profit Margin351938
Profit Before Tax580202862
Dividends Per Share550
Operation Revenue2,1562,0442,812

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
202300377.40NA868.45
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Natco Pharma is 0 as of 5/30/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20132013201320132015
Operating Activities6161616193
Investing Activities-107-107-107-107-115
Financing Activities2626262629
Others00000
Net Cash Flow-20-20-20-207

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20201,392.41-783.52-444.66164.23
20201,468.841,106.99-890.581,685.25
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Natco Pharma is 93 as of 5/30/2023